AMJ Podcast | Episode 4: Capivasertib in the Clinic: Strategies to Manage Adverse Events

EMJ Podcast: Insights For Healthcare Professionals · Nov 25, 2025 · 1m

AMJ Podcast | Episode 4 Capivasertib in the Clinic: Strategies to Manage Adverse Events This content was funded by AstraZeneca, and is intended for US Healthcare Professionals. Expert opinions are shared in this program and may differ from the approved capivasertib (TRUQAP®) labeling. Please see full Prescribing Information, including Patient Information when making treatment decisions. Indication and Usage Capivasertib (TRUQAP®) in combination with fulvestrant is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2…